Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.6 CHF | +7.30% |
|
+8.01% | +20.40% |
06-20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
06-20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.40% | 536M | |
+24.28% | 46.56B | |
+45.66% | 41.67B | |
-0.34% | 41.16B | |
+33.62% | 32.4B | |
+20.46% | 28.18B | |
-6.35% | 28.1B | |
+49.59% | 14.52B | |
+47.78% | 13.74B | |
+2.07% | 12.17B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Transcript : Basilea Pharmaceutica AG Presents at JP Morgan 37th Annual Healthcare conference, Jan-10-2019 08